
Vial Announces the Addition of Dr. Christopher Sweeney of SAiGENCI and the University of Adelaide to their Oncology CRO Scientific Advisory Board ⋆ Vial
San Francisco, CA. December 19, 2022 — Vial, a global tech-enabled CRO providing next-generation clinical trial management services, announced the addition of Christopher Sweeney, MBBS, to Vial’s scientific advisory board (SAB). Dr. Sweeney will work closely with the company’s leadership team to shape the scientific strategy of Vial’s Oncology CRO products and services.
“We are beyond thrilled that an eminent scientist such as Dr. Sweeney has decided to join our CRO’s Oncology SAB. He has had a
“We are beyond thrilled that an eminent scientist such as Dr. Sweeney has decided to join our CRO’s Oncology SAB. He has had a